Coya Therapeutics, Inc. Share Price Today, Financials & AI Analysis — Stockinder

Jarvis is thinking

Coya Therapeutics, Inc. Share Price Today, Financials & AI Analysis — Stockinder

Income Statement

	2025-12-31	2024-12-31	2022-12-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	$7.95M	$3.55M	–
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	-$22.56M	-$17.25M	-$9.81M
Operating income as a percentage of revenue.	-283.9%	-485.4%	–
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	-$21.23M	-$14.88M	-$12.24M
Net income divided by the number of shares outstanding — profit attributable to each share.	$-1.00	$0.00	$-4.00
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$-1.00	$0.00	$-4.00

Balance Sheet

	2025-12-31	2024-12-31	2022-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$46.80M	$38.30M	$5.93M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$49.95M	$44.35M	$8.40M
Everything the company owes — debt, unpaid bills, and other obligations.	$6.92M	$4.77M	$16.79M
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$43.03M	$39.58M	-$8.39M

Cash Flow Statement

	2025-12-31	2024-12-31	2022-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	-$10.74M	-$10.29M	-$7.24M